Inventor · disambiguated record
Helmut Haning
Also filed as: BISCHOFF ERWIN · ES-SAYED MAZEN · HANING HELMUT · LAMPE THOMAS
27 granted patents·15 pending applications·586 citations·filing 1998–2012
97Inventor score
Files withBAYER AG19BAYER HEALTHCARE AG11BAYER SCHERING PHARMA AG3BAYER PHARMACEUTICALS CORP2BAYER AKTLENGESELLSCHAFT1
Top patents by PatentIndex Score
42 records- 0197US6362178B12-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER AG·Filed 1998·Granted Mar 26, 2002·165 cites·8 claims
- 0295US6566360B12-phenyl substituted imidatriazinones as phosphodiesterase inhibitorsBAYER AG·Filed 2001·Granted May 20, 2003·51 cites·4 claims
- 0393US7314871B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertensionBAYER AG·Filed 2006·Granted Jan 1, 2008·18 cites·2 claims
- 0492US7696206B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER SCHERING PHARMA AG·Filed 2009·Granted Apr 13, 2010·12 cites·6 claims
- 0590US7122540B22-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER HEALTHCARE AG·Filed 2004·Granted Oct 17, 2006·25 cites·2 claims
- 0690US6890922B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER HEALTHCARE AG·Filed 2003·Granted May 10, 2005·25 cites·18 claims
- 0787US7704999B22-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER SCHERING PHARMA AG·Filed 2007·Granted Apr 27, 2010·6 cites·9 claims
- 0886US6608049B2IndazolesBAYER AG·Filed 2001·Granted Aug 19, 2003·20 cites·17 claims
- 0986US6174884B11,5-dihydro-pyrazolo[34-D]-pyrimidinone derivativesBAYER AG·Filed 1998·Granted Jan 16, 2001·79 cites·9 claims
- 1085US7098207B2Imidazotriazinones and the use thereofBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Aug 29, 2006·7 cites·5 claims
- 1184US6794406B2Indole derivativesBAYER AG·Filed 2001·Granted Sep 21, 2004·23 cites·14 claims
- 1283US6803365B2Imidazo[1,3,5]triazinones and the use thereofBAYER AKTLENGESELLSCHAFT·Filed 2000·Granted Oct 12, 2004·23 cites·9 claims
- 1381US7015246B2Benzofuran derivativesBAYER AG·Filed 2002·Granted Mar 21, 2006·16 cites·10 claims
- 1480US7091203B2Imidazo[1,3,5]triazinones and their useBAYER HEALTHCARE AG·Filed 2004·Granted Aug 15, 2006·12 cites·3 claims
- 1580US6943163B27-Alkyl and cycloalkyl-substituted imidazotriazinonesBAYER AG·Filed 2004·Granted Sep 13, 2005·11 cites·5 claims
- 1678US6683081B2Triazolotriazinones and the use thereofBAYER AG·Filed 2000·Granted Jan 27, 2004·10 cites·7 claims
- 1775US6458796B1Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-oneBAYER AG·Filed 1999·Granted Oct 1, 2002·38 cites·10 claims
- 1871US6777442B2Diphenyl derivativesBAYER AG·Filed 2002·Granted Aug 17, 2004·6 cites·12 claims
- 1970US6878708B2Imidazotriazinones and the use thereofBAYER AG·Filed 2001·Granted Apr 12, 2005·4 cites·12 claims
- 2069US7276504B2Use of 2-alkoxyphenyl-substituted imidazotriazinonesBAYER HEALTHCARE AG·Filed 2005·Granted Oct 2, 2007·1 cites·3 claims
- 2169US6838459B17-alkyl-and cycloalkyl-substituted imidazotriazinonesBAYER AG·Filed 2002·Granted Jan 4, 2005·3 cites·1 claims
- 2266US6803480B2Diphenylmethane derivativesBAYER AG·Filed 2001·Granted Oct 12, 2004·3 cites·12 claims
- 2366US6476029B17-alkyl- and cycloalkyl-substituted imidazotriazinonesBAYER AG·Filed 1999·Granted Nov 5, 2002·18 cites·11 claims
- 2465US6555580B2Amino- and amido-diphenyl ethersBAYER AG·Filed 2001·Granted Apr 29, 2003·4 cites·8 claims
- 2564US6930108B2Use of 2-alkoxyphenol-substituted imidazotriazinonesBAYER HEALTHCARE AG·Filed 2002·Granted Aug 16, 2005·3 cites·3 claims
- 2662US2013059844A12-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsNIEWOEHNER ULRICH·Filed 2012·Application pending·0 cites
- 2756US2011009367A12-phenyl substituted imidazotriazinones as phosphodiesterase inhibitorsBAYER SCHERING PHARMA AG·Filed 2010·Application pending·0 cites
- 2856US2008085897A1Use of 2-alkoxyphenyl-substituted imidazotriazinonesBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 2952US2005096320A1Triazolotriazinones and the use thereofBAYER PHARMACEUTICALS CORP·Filed 2003·Application pending·0 cites
- 3051US2005032874A1Indole derivativesBAYER AG·Filed 2003·Application pending·0 cites
- 3146US2004152700A1Novel use of 2-phenyl-substituted imidazotriazinonesFiled 2002·Application pending·0 cites
- 3245US2008096880A1Novel use of imidazotriazinonesBAYER HEAKTHCARE AG·Filed 2003·Application pending·0 cites
- 3344US2009221570A1Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives for Treating Pulmonary HypertensionBAYER HELTHCARE AG·Filed 2006·Application pending·0 cites
- 3444US2006148802A1Use of compounds that stimulate cgmpBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 3543US2008280914A1Intravenous Formulations of Pde InhibitorsBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3642US2007299088A1Novel Uses of 2-Phenyl-Substituted Imidazotriazinone DerivativesBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3740US6777416B2Isoxazolo pyrimidinones and the use thereofBAYER AG·Filed 2000·Granted Aug 17, 2004·0 cites·9 claims
- 3840US2008268046A1Formulations with Controlled Release of Active IngredientBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3940US2008187588A1Formulations With Controlled Release Of Active IngredientBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 4038US2006160810A12-Alkoxyphenyl substituted imidazotriazinonesNIEWOHNER ULRICH·Filed 2002·Application pending·0 cites
- 4137US6900194B1Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseasesBAYER AG·Filed 1999·Granted May 31, 2005·3 cites·12 claims
- 4237US2004235830A1Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseasesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Helmut Haning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →